REPROCELL Europe Ltd

REPROCELL Europe Ltd is a Contract Research Organisation specialising in the use of fresh human tissues to better predict drug efficacy and safety during non-clinical drug development. We source a range of fresh healthy and diseased tissues from multiple providers, across the UK, Europe and the USA, for specific academic and pharmaceutical industry sponsored projects conducted within REPROCELL facilities. Services utilising fresh tissue include pharmacological assays, 3-D culture and induced pluripotent stem cell production using our exclusive RNA re-programming technology. Through our REPROCELL partner group we also have access to a global biorepository of human serum, DNA, RNA and FFPE samples.

Services

  • Cell culture
  • Human functional tissue assays
  • IPSC reprogramming services
  • Nucleic acid extraction

Bespoke collection capabilities:

  • Asthma (disorder)
  • Chronic obstructive lung disease (disorder)
  • Diabetes mellitus type 1 (disorder)
  • Diabetes mellitus type 2 (disorder)
  • Fit and well (finding)
  • Hypertensive disorder, systemic arterial (disorder)
  • Inflammatory bowel disease (disorder)
  • Ischemic heart disease (disorder)

Networks

  • Scientist.com

Contact Information

Email:
info-emea@reprocell.com
Address:

Thomson Pavilion
Todd Campus
West of Scotland Science Park
Acre Road
Glasgow
Glasgow (City of)
G20 0XA
Scotland

Last Updated: 05/06/2018


Annual Statistics

Year Access Requests Received Access Requests Approved
Internal External Commercial Internal External Commercial
2015 N/A N/A N/A N/A N/A N/A
2016 N/A N/A N/A N/A N/A N/A
2017 N/A N/A N/A N/A N/A N/A
2018 N/A N/A N/A N/A N/A N/A
2019 N/A N/A N/A N/A N/A N/A
2020 N/A N/A N/A N/A N/A N/A
2021 N/A N/A N/A N/A N/A N/A
2022 N/A N/A N/A N/A N/A N/A
2023 N/A N/A N/A N/A N/A N/A
2024 N/A N/A N/A N/A N/A N/A